← All trials
NCT00656422
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2007
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 66
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of TuebingenLead sponsor
- Medical University of GrazOverall official - principal investigator
- University of ViennaStudy chair
- University of BernStudy chair
- University of BernCollaborator
- University of ViennaCollaborator
- CenTrial GmbHCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.